Personalized genomic medicine has long been expected to blossom as sequencing of an individual’s human genome is nearing the $1,000 mark. In a remarkable new story, one professor, who sequenced his own genome, found that he was a high risk for Type 2 diabetes—then used blood tests to find out if he might develop the disease. Seven months into the experiment, he developed diabetes and began treatment, long before it might have been if the professor had relied on a conventional visits to the doctor.Additional Resources:
